Generation of vaccine‐primed lymphocytes for the treatment of head and neck cancer

Abstract

Both CD4(+) and CD8(+) responses can be induced to SCC by autologous tumor vaccination. However, additional approaches need to be identified to enhance the therapeutic efficacy of this approach.